These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 31642423)

  • 1. Natural History of Treated Subarachnoid Neurocysticercosis.
    Nash TE; O'Connell EM; Hammoud DA; Wetzler L; Ware JM; Mahanty S
    Am J Trop Med Hyg; 2020 Jan; 102(1):78-89. PubMed ID: 31642423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subarachnoid neurocysticercosis: emerging concepts and treatment.
    Nash TE; O'Connell EM
    Curr Opin Infect Dis; 2020 Oct; 33(5):339-346. PubMed ID: 32868512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Etanercept to Control Inflammation in the Treatment of Complicated Neurocysticercosis.
    Nash TE; Ware JM; Coyle CM; Mahanty S
    Am J Trop Med Hyg; 2019 Mar; 100(3):609-616. PubMed ID: 30608049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolonged perilesional edema after treatment of parenchymal neurocysticercosis: methotrexate as a corticosteroid-sparing agent.
    Keiser PB; Nash TE
    Clin Infect Dis; 2003 May; 36(10):e122-6. PubMed ID: 12746791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Giant racemose subarachnoid and intraventricular neurocysticercosis: A case report].
    Sanchez-Larsen A; Monteagudo M; Lozano-Setien E; Garcia-Garcia J
    Rev Argent Microbiol; 2015; 47(3):201-5. PubMed ID: 26321177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subarachnoidal Neurocysticercosis non-responsive to cysticidal drugs: a case series.
    Cárdenas G; Carrillo-Mezo R; Jung H; Sciutto E; Hernandez JL; Fleury A
    BMC Neurol; 2010 Mar; 10():16. PubMed ID: 20202200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meta-analysis: Cysticidal drugs for neurocysticercosis: albendazole and praziquantel.
    Del Brutto OH; Roos KL; Coffey CS; García HH
    Ann Intern Med; 2006 Jul; 145(1):43-51. PubMed ID: 16818928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monitoring treatment of Taenia solium- neurocysticercosis by detection of circulating antigens: a case report.
    Rodríguez-Hidalgo R; Carpio A; Van den Enden E; Benítez-Ortiz W
    BMC Neurol; 2019 Apr; 19(1):52. PubMed ID: 30943908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of combined treatment with praziquantel and albendazole in neurocysticercosis.
    Garcia HH; Lescano AG; Lanchote VL; Pretell EJ; Gonzales I; Bustos JA; Takayanagui OM; Bonato PS; Horton J; Saavedra H; Gonzalez AE; Gilman RH;
    Br J Clin Pharmacol; 2011 Jul; 72(1):77-84. PubMed ID: 21332573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intramedullary spinal neurocysticercosis treated successfully with medical therapy.
    Ahmed S; Paul SP
    J Egypt Soc Parasitol; 2014 Dec; 44(3):661-4. PubMed ID: 25643507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of combined antiparasitic therapy with praziquantel and albendazole for neurocysticercosis: a double-blind, randomised controlled trial.
    Garcia HH; Gonzales I; Lescano AG; Bustos JA; Zimic M; Escalante D; Saavedra H; Gavidia M; Rodriguez L; Najar E; Umeres H; Pretell EJ;
    Lancet Infect Dis; 2014 Aug; 14(8):687-695. PubMed ID: 24999157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intraventricular and subarachnoid basal cisterns neurocysticercosis: a comparative study between traditional treatment versus neuroendoscopic surgery.
    Proaño JV; Torres-Corzo J; Rodríguez-Della Vecchia R; Guizar-Sahagun G; Rangel-Castilla L
    Childs Nerv Syst; 2009 Nov; 25(11):1467-75. PubMed ID: 19557421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Routine drug and food interactions during antihelminthic treatment of neurocysticercosis: a reason for the variable efficacy of albendazole and praziquantel?
    Romo ML; Carpio A; Kelvin EA
    J Clin Pharmacol; 2014 Apr; 54(4):361-7. PubMed ID: 24443292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current approaches to cysticidal drug therapy for neurocysticercosis.
    Del Brutto OH
    Expert Rev Anti Infect Ther; 2020 Aug; 18(8):789-798. PubMed ID: 32331507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medical treatment for neurocysticercosis characterized by giant subarachnoid cysts.
    Proaño JV; Madrazo I; Avelar F; López-Félix B; Díaz G; Grijalva I
    N Engl J Med; 2001 Sep; 345(12):879-85. PubMed ID: 11565520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of neurocysticercosis: a review].
    Nogales-Gaete J; Arriagada C; Salinas R
    Rev Med Chil; 2006 Jun; 134(6):789-96. PubMed ID: 17130956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cysticidal Efficacy of Combined Treatment With Praziquantel and Albendazole for Parenchymal Brain Cysticercosis.
    Garcia HH; Lescano AG; Gonzales I; Bustos JA; Pretell EJ; Horton J; Saavedra H; Gonzalez AE; Gilman RH;
    Clin Infect Dis; 2016 Jun; 62(11):1375-9. PubMed ID: 26984901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxfendazole Nitazoxanide combination in experimental neurocysticercosis - Anti-inflammatory and cysticidal effects.
    Araújo JAA; Gomes TC; Lima VCN; Silva YBD; Lino Junior RS; Vinaud MC
    Exp Parasitol; 2024 Jul; 262():108764. PubMed ID: 38677580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination therapy with albendazole and praziquantel versus albendazole alone in children with seizures and single lesion neurocysticercosis: a randomized, placebo-controlled double blind trial.
    Kaur S; Singhi P; Singhi S; Khandelwal N
    Pediatr Infect Dis J; 2009 May; 28(5):403-6. PubMed ID: 19325515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic variability of anthelmintics: implications for the treatment of neurocysticercosis.
    Jung-Cook H
    Expert Rev Clin Pharmacol; 2012 Jan; 5(1):21-30. PubMed ID: 22142156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.